PHA Preceptorship: Michigan

Please note - a separate email address is required for each medical professional attending the program.

PHA Preceptorship Program: A Collaborative Approach for Clinicians on the Front Line

Webinar and Zoom links sent upon registration. There is no fee for this program. 

SESSION 1: CORE CONCEPTS
Available to view at your convenience, prior to attendance of Session 2 on September 21, 2021

Session 1 Faculty
Jean M. Elwing, MD, FCCP, National Chair
Professor of Medicine
Director, Pulmonary Hypertension Program
Division of Pulmonary, Critical Care, and Sleep Medicine
University of Cincinnati College of Medicine
Cincinnati, Ohio

Kelly M. Chin, MD, MSCS
Associate Professor of Medicine
Director, Pulmonary Hypertension Program
Division of Pulmonary and Critical Care Medicine
University of Texas Southwestern Medical Center
Dallas, Texas

Christopher F. Barnett, MD, MPH
Associate Clinical Professor of Medicine
Chief, Section of Critical Care Cardiology
Division of Cardiology
University of California, San Francisco School of Medicine
San Francisco, California

Session 1 Program
Overview of Pulmonary Hypertension: Epidemiology and Pathophysiology
Diagnosis and Assessment of Pulmonary Hypertension
Treatment Modalities for Pulmonary Arterial Hypertension
Risk Assessment and Selection of Appropriate Therapy
A Closer Look at Vasodilator Challenge and When Calcium Channel Blocker Treatment of Pulmonary Arterial Hypertension Is Appropriate

SESSION 2: SPECIALIZED TOPICS AND CLINICAL CASES
Live Online with Local Leaders in PH

Tuesday, September 21, 2021
3:00 - 5:30 PM EDT

Session 2 Faculty
Vallerie V. McLaughlin, MD, FACC, FAHA, FCCP, Moderator
Kim A. Eagle Endowed Professor and Associate Chief of Cardiovascular Medicine
Director, Pulmonary Hypertension Program
Michigan Medicine
Ann Arbor, Michigan

Sara H. Hegab, MD
Assistant Professor of Medicine
Wayne State University School of Medicine
Associate Director, Pulmonary Hypertension Program
Medical Director, Pulmonary Embolism Response Team
Division of Pulmonary and Critical Care Medicine
Henry Ford Hospital
Detroit, Michigan

Victor M. Moles, MD
Assistant Clinical Professor of Medicine
Division of Cardiovascular Medicine
Pulmonary Hypertension Program
Michigan Medicine
Ann Arbor, Michigan

Session 2 Program
Chronic Thromboembolic Pulmonary Hypertension
Pulmonary Hypertension Due to Left Heart Disease
Interactive Cases Across Pulmonary Hypertension Groups
Live Q&A and Discussion

Target Audience

This activity has been designed for pulmonologists, cardiologists, rheumatologists, internists, and primary care physicians, as well as nurses, physician assistants, and other allied health professionals who help care for patients with pulmonary arterial hypertension (PAH).

Educational Objectives

The PHA Preceptorship Program is designed to improve competence, performance, and patient care practices by instructing front-line clinicians in the highest quality of case for patients with PAH by combining didactic discourse and highly interactive case-based discussion. At the conclusion of this program, participants should be able to:

• Define key pathophysiologic and epidemiologic components of PAH
  
• Accurately diagnose patients through comprehensive screening and early recognition of symptoms
  
• Evaluate the patient's condition and prescribe optimal long-term management, including knowing when and how to treat and when to consult with colleagues at an established PAH center
  
• Tailor comprehensive care for complex patient populations

  ---

Accreditation 

In support of improving patient care, this activity has been planned and implemented by Washington University School of Medicine in St. Louis, Continuing Medical Education and the Pulmonary Hypertension Association. Washington University School of Medicine in St. Louis is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Awarded for This Activity 

Washington University School of Medicine in St. Louis designates this internet live activity for a maximum of 5 AMA PRA Category 1 Credits™, with 2.5 AMA PRA Category 1 Credits™ available per session. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Statement

It is the policy of Washington University School of Medicine in St. Louis, Continuing Medical Education, that planners, faculty and other persons who may influence content of this CME activity disclose all relevant financial relationships with commercial interests in order for CME staff to identify and resolve any potential conflicts of interest prior to the educational activity. Faculty must also disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation. Detailed disclosures will be made in activity handout materials.

Preceptorship Medical Education Program Committee Members

Jean M. Elwing, MD, FCCP (Committee Chair), University of Cincinnati College of Medicine; Eric D. Austin, MD, MSCI, Vanderbilt University School of Medicine; Christopher F. Barnett, MD, MPH, University of California, San Francisco School of Medicine; Kelly Chin, MD, MSCS, University of Texas Southwestern Medical Center; Richard A. Krasuski, MD, FACC, FAHA, FESC, Duke University School of Medicine; Gustavo A. Heresi, MD, MS, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University; Tim Lahm, MD, National Jewish Health; Vallerie V. McLaughlin, MD, FACC, FAHA, FCCP (Advisor), Michigan Medicine

Washington University School of Medicine in St. Louis, CME Reviewers

Murali M. Chakinala, MD, FCCP — Content
Allyson R. Zazulia, MD — CME

This activity is supported by educational grants from: